Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies
Recruiting now
Conditions studied: Patellar Tendinopathy, Achilles Tendinopathy (AT), Epicondylitis, Lateral, Plantar Fasciitis, Chronic
In brief
This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.
Key facts
- Study ID
- NCT07558564
- Run by
- ReSport Clinic
- People needed
- 2000
- Starts
- 2026-04-01
- Expected to finish
- 2028-03-01
- Last updated by the study team
- 2026-04-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Clinical and/or ultrasound diagnosis of chronic tendinopathy (duration >6 weeks)
- Age >18 years
- Provision of written informed consent
- Willingness and ability to complete follow-up assessments for 12 months
You may not qualify if…
- Surgical treatment of the affected tendon within the previous 6 months
- Corticosteroid injection within the last month
- Systemic inflammatory disease (e.g., rheumatoid arthritis)
- Coagulopathies or ongoing anticoagulant therapy
- Complete blood count showing a platelet concentration <100 × 10⁹/L (to exclude patients with potential thrombocytopenia)
- Pregnancy or breastfeeding
Where it is running
- Instituto Médico Arriaza — A Coruña, Spain (enrolling)
- Instituto Cugat — Barcelona, Spain (enrolling)
- ReSport Clinic — Barcelona, Spain (enrolling)
- Ripoll y dePrado Medical Group — Madrid, Spain (enrolling)
- Hospital MIKS — Vitoria-Gasteiz, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.